Ultragenyx (RARE) — Cash Flow-to-Debt Ratio
Ultragenyx (RARE) has a Cash Flow-to-Debt Ratio of -0.13x as of March 2026, meaning its operating cash flow of $-197.00 Million could theoretically repay 0% of its total liabilities ($1.52 Billion) in one year. See free cash flow generation of Ultragenyx to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Ultragenyx Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Ultragenyx across 15 annual periods. Also explore RARE year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Ultragenyx (2011–2025)
Year-by-year debt coverage analysis for Ultragenyx. For market capitalisation and broader financial context, see market value of Ultragenyx.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.29x | $-466.00 Million | $1.60 Billion | ▲ +13.0% |
| 2024 | -0.33x | $-414.19 Million | $1.24 Billion | ▲ +14.6% |
| 2023 | -0.39x | $-474.81 Million | $1.22 Billion | ▼ -22.5% |
| 2022 | -0.32x | $-380.46 Million | $1.19 Billion | ▲ +43.5% |
| 2021 | -0.56x | $-338.69 Million | $599.84 Million | ▼ -158.4% |
| 2020 | -0.22x | $-132.22 Million | $605.18 Million | ▲ +69.5% |
| 2019 | -0.72x | $-345.38 Million | $481.73 Million | ▲ +72.7% |
| 2018 | -2.63x | $-290.57 Million | $110.65 Million | ▼ -11.0% |
| 2017 | -2.37x | $-253.84 Million | $107.30 Million | ▲ +2.0% |
| 2016 | -2.42x | $-160.97 Million | $66.65 Million | ▲ +35.1% |
| 2015 | -3.72x | $-105.98 Million | $28.48 Million | ▼ -8.6% |
| 2014 | -3.43x | $-44.63 Million | $13.02 Million | ▼ -4.8% |
| 2013 | -3.27x | $-31.20 Million | $9.54 Million | ▼ -4.0% |
| 2012 | -3.14x | $-12.50 Million | $3.98 Million | ▲ +19.8% |
| 2011 | -3.92x | $-5.83 Million | $1.49 Million | — |